Meeting
2022 ASCO Genitourinary Cancers Symposium
Evaluating therapeutic bladder cancer trial disparities in race/ethnicity.
Authors
Ishaan Iyer
University of California, Davis, Davis, CA
Ishaan Iyer , Sylvia Zhang , Hala Borno
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Cancer Disparities
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 446)
DOI
10.1200/JCO.2022.40.6_suppl.446
Abstract #
446
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Identification of muscle-invasion status in bladder cancer patients using natural language processing and machine learning.
First Author: Ruixin Yang
Poster
2020 Genitourinary Cancers Symposium
Comprehensive targeted gene profiling to determine the genomic signature likely to drive progression of high-grade nonmuscle invasive bladder cancer to muscle invasive bladder cancer.
First Author: Abedalrhman Alkhateeb
Poster
2018 Genitourinary Cancers Symposium
Vascular and tumor cell expression of VEGFR2 and molecular subtyping: An innovative biomarker approach in bladder cancer.
First Author: Aejaz Nasir
Poster
2015 Genitourinary Cancers Symposium
Genomic landscape of high-grade T1 micropapillary bladder tumors.
First Author: Joaquim Bellmunt